Dec 03, 2024
OncoHost Earns CAP Accreditation for Cary Laboratory, Highlighting Commitment to Excellence in Proteomic-Based Diagnostics
Nov 13, 2024
OncoHost Announces Executive Appointment of Ron Andrews
Sep 10, 2024
OncoHost Accepted to Present Poster Demonstrating PROphet®'s Application in Renal Cell Carcinoma at ESMO 2024
Aug 14, 2024
OncoHost Announces Three Abstracts Selected for Presentation at WCLC 2024
Jul 29, 2024
Clinical Lung Cancer Publishes Study: 93% of Oncologists Adjust Treatment Recommendations with OncoHost's PROphetNSCLC(TM) Test
Jun 02, 2024
OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
May 23, 2024
OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at ASCO 2024
Mar 21, 2024
JCO® Precision Oncology (JCO PO) Publishes Study Demonstrating Clinical Validity and Utility of OncoHost's PROphet® NSCLC Test
Mar 20, 2024
OncoHost Wins 2024 Artificial Intelligence Excellence Award
Mar 05, 2024
OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024
Jan 19, 2021
OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform
Jan 11, 2021
OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board
Nov 09, 2020
OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020
Oct 05, 2020
OncoHost to Present Data on Predicting Host Response to Immunotherapy at the MAP 2020 Virtual Congress - ESMO
Sep 17, 2020
OncoHost to Present Data on Host Response Profiling for NSCLC Patients at ESMO Virtual Congress 2020
May 14, 2020
OncoHost to Present Data on Host Response Profiling for Melanoma Patients at 2020 ASCO Annual Meeting